Literature DB >> 3681665

The phenomenon and cause of the dose-dependent oral absorption of chlorothiazide in rats: extrapolation to human data based on the body surface area concept.

F H Hsu1, T Prueksaritanont, M G Lee, W L Chiou.   

Abstract

The reported incomplete and dose-dependent absorption of chlorothiazide in humans was demonstrated in six rats after five oral solutions at doses of 0.93, 2.55, 9.23, 25.6, and 70.2 mg/kg. Mean 48-hr urinary recoveries of intact drug were 57.3, 50.4, 36.7, 22.8, and 15.3%, respectively. A similar degree of dose dependency in absorption was found in rat, dog, and human when the doses were related to unit body surface area (BSA) but not on unit body weight, indicating similar interspecies absorptive capacity in terms of unit BSA. This finding may be partly rationalized by marked similarities in the reported solution transit time (2-3 hr) in the small intestine as well as in the calculated gross surface area of the small intestine per unit BSA (0.163 for rat and 0.132 for human). Contrary to the previous postulation of a specific absorption site, the drug was absorbed from different regions of the GI tract with apparent 1-hr absorption rates, studied by the in situ closed-loop method, in the following rank order: jejunum (34.6%) greater than duodenum (32.7%) greater than large intestine (20.1%) greater than ileum (18.0%) greater than stomach (12.4%). Different from the commonly assumed first-order absorption process, the intestinal loop absorption was concentration-dependent, suggesting a saturable mechanism. For example, the absorption rate at 0.008 mg/mL was higher than that at 0.2 mg/mL in ileal loops (61%, p less than 0.01) and jejunal loops (22%, p less than 0.1). In addition, the absorption rates at pH 6 and 7.4 were statistically identical, indicating a lack of ionization effect that is important in the passive absorption process. The solubility-limited absorption could probably be ruled out at doses below 2.55 mg/kg for rat and 125 mg for human in view of higher aqueous solubilities at 37 degrees C (e.g., 1.3 mg/mL at pH 7) found in the present study. Contrary to the previous hypothesis of low membrane permeability as a limiting factor for absorption, the "intrinsic" partition coefficient in 1-octanol/aqueous buffer was moderate, 0.6. Furthermore, the absorption in ileal and jejunal loops was enhanced by an apparent increase in mesenteric blood flow by caffeine. The existence of prolonged oral absorption in rats and humans is discussed.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3681665     DOI: 10.1007/bf01066519

Source DB:  PubMed          Journal:  J Pharmacokinet Biopharm        ISSN: 0090-466X


  24 in total

1.  Studies with chlorothiazide tagged with radioactive carbon (C14) in human beings.

Authors:  H R BRETTELL; J K AIKAWA; G S GORDON
Journal:  Arch Intern Med       Date:  1960-07

2.  Use of radioyttrium to study food movement in the small intestine of the rat.

Authors:  C S Marcus; F W Lengemann
Journal:  J Nutr       Date:  1962-02       Impact factor: 4.798

3.  Simplification of drug dosage calculation by application of the surface area principle.

Authors:  J D CRAWFORD; M E TERRY; G M ROURKE
Journal:  Pediatrics       Date:  1950-05       Impact factor: 7.124

4.  Methylxanthines and intestinal drug absorption.

Authors:  E Beubler; F Lembeck
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1976       Impact factor: 3.000

5.  The influence of blood flow on the absorption of L- and D-phenylalanine from the jejunum of the rat.

Authors:  D Winne
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1973       Impact factor: 3.000

6.  High-pressure liquid chromatographic determination of chlorothiazide and hydrochlorothiazide in plasma and urine: preliminary results of clinical studies.

Authors:  R H Barbhaiya; T A Phillips; P G Welling
Journal:  J Pharm Sci       Date:  1981-03       Impact factor: 3.534

7.  Thiazides IV: Comparison of dissolution with bioavailability of chlorothiazide tablets.

Authors:  V P Shah; P Knight; V K Prasad; B E Cabana
Journal:  J Pharm Sci       Date:  1982-07       Impact factor: 3.534

Review 8.  Comparative drug metabolism.

Authors:  L B Mellett
Journal:  Prog Drug Res       Date:  1969

9.  The effect of dosage on the bioavailability of chlorothiazide administered in solution.

Authors:  O I Corrigan; K M O'Driscoll
Journal:  J Pharm Pharmacol       Date:  1980-08       Impact factor: 3.765

10.  Chlorothiazide absorption from solution and tablet dosage forms in dogs.

Authors:  W F Ebling; A F Murro; F J Voelker; D E Resetarits; T R Bates
Journal:  J Pharm Sci       Date:  1981-02       Impact factor: 3.534

View more
  10 in total

1.  Poor and unusually prolonged oral absorption of amphotericin B in rats.

Authors:  G Robbie; T C Wu; W L Chiou
Journal:  Pharm Res       Date:  1999-03       Impact factor: 4.200

2.  Mechanisms of food effects of structurally related antiarrhythmic drugs, disopyramide and bidisomide in the rat.

Authors:  K H Lee; G X Xu; G L Schoenhard; C S Cook
Journal:  Pharm Res       Date:  1997-08       Impact factor: 4.200

3.  A physiologic model for simulating gastrointestinal flow and drug absorption in rats.

Authors:  Stefan Willmann; Walter Schmitt; Jörg Keldenich; Jennifer B Dressman
Journal:  Pharm Res       Date:  2003-11       Impact factor: 4.200

4.  Linear correlation of the fraction of oral dose absorbed of 64 drugs between humans and rats.

Authors:  W L Chiou; A Barve
Journal:  Pharm Res       Date:  1998-11       Impact factor: 4.200

5.  Pharmacokinetics and pharmacodynamics of azosemide after intravenous and oral administration to rats: absorption from various GI segments.

Authors:  S H Lee; M G Lee
Journal:  J Pharmacokinet Biopharm       Date:  1996-12

6.  Evaluation of using dog as an animal model to study the fraction of oral dose absorbed of 43 drugs in humans.

Authors:  W L Chiou; H Y Jeong; S M Chung; T C Wu
Journal:  Pharm Res       Date:  2000-02       Impact factor: 4.200

7.  Apparent lack of effect of P-glycoprotein on the gastrointestinal absorption of a substrate, tacrolimus, in normal mice.

Authors:  W L Chiou; S M Chung; T C Wu
Journal:  Pharm Res       Date:  2000-02       Impact factor: 4.200

8.  Risk of death does not alter the efficacy of hydrocortisone therapy in a mouse E. coli pneumonia model: risk and corticosteroids in sepsis.

Authors:  Yan Li; Xizhong Cui; Xuemei Li; Steven B Solomon; Robert L Danner; Steven M Banks; Yvonne Fitz; Djillali Annane; Charles Natanson; Peter Q Eichacker
Journal:  Intensive Care Med       Date:  2007-11-09       Impact factor: 17.440

9.  Correlation of unbound plasma clearances of fifteen extensively metabolized drugs between humans and rats.

Authors:  W L Chiou; F H Hsu
Journal:  Pharm Res       Date:  1988-10       Impact factor: 4.200

10.  Pharmacokinetics and pharmacodynamics of bumetanide after intravenous and oral administration to rats: absorption from various GI segments.

Authors:  S H Lee; M G Lee; N D Kim
Journal:  J Pharmacokinet Biopharm       Date:  1994-02
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.